Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/5311
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMehta, Priti-
dc.date.accessioned2015-01-21T05:36:53Z-
dc.date.available2015-01-21T05:36:53Z-
dc.date.issued2014-
dc.identifier.urihttp://hdl.handle.net/123456789/5311-
dc.description.abstractMilnacipran hydrochloride is an antidepressant drug, belonging to a class of selective serotonin re-uptake inhibitors. Unknown impurity in active pharmaceutical ingredient and pharmaceutical formulation of Milnacipran hydrochloride was found to be 0.08% and 0.12%, respectively, by peak area, with sensitive, isocratic RP-HPLC method. As per revised guidelines of International Conference on Harmonization Q3A (R2) and Q3B (R2), impurity profiling should be done for drug substances and drug products to identify and characterize all the unknown impurities that are present at level above 0.05%. This unknown impurity was targeted and isolated by developed Prep-HPLC method. The isolated impurity is characterized as 1-phenyl-3-azabicyclo [3.1.0] hexan-2-one using spectroscopic techniques like FT-IR, Mass, and NMR. The origin of the impurity is also postulated by proposing the plausible mechanism of formation.en_US
dc.publisherTaylor & Francis Groupen_US
dc.relation.ispartofseriesIPFP0119;-
dc.subjectcharacterization, FT-IRen_US
dc.subjectliquid chromatographyen_US
dc.subjectidentificationen_US
dc.subjectNMR spectroscopyen_US
dc.subjectunknown impurityen_US
dc.titleIsolation and Characterization of Related Impurity in Milnacipran Hydrochloride Active Pharmaceutical Ingredient.en_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0119.pdfIPFP0119464.57 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.